Jobaaj Stories
Empuraan Collection Worldwide: A Box Office Phenomenon
Mohanlal's L2: Empuraan, the highly anticipated sequel to the blockbuster Lucifer, has taken the global box office by storm. Directed by Prithviraj Sukumaran, this political action thriller is shattering records and making history for Malayalam cinema.
A Record-Breaking Opening
Empuraan aimed for a massive global opening of Rs 65 crore, a target easily surpassed. Pre-sales alone generated approximately Rs 52 crore, leaving only the spot bookings and walk-ins to achieve the ambitious goal. This phenomenal start speaks volumes about the film's popularity and Mohanlal's enduring star power. In fact, the movie's opening-day collection surpassed the entire four-day collection of Prithviraj Sukumaran's previous hit, Aadujeevitham! Even more impressively, Empuraan exceeded the four-day opening weekend gross of its prequel, Lucifer (Rs 55.40 crore), on its first day alone – a truly remarkable achievement for a sequel in the Indian film industry.
Domestic and International Success
Early estimates suggest L2: Empuraan earned between Rs 22-24 crore on its opening day in India, a significant increase from the previous highest Malayalam opener post-COVID. This, combined with strong international numbers, pushed the worldwide gross to approximately Rs 65 crore on Day 1. The film has already secured a place among the top-grossing Malayalam films of 2025.
Critical Acclaim and Fan Response
Empuraan's success isn't solely driven by impressive box office figures. The film has garnered positive reviews for its bold political themes, thrilling action sequences, and strong performances. While some critics note a dip in pace during the second half, the overall response has been largely enthusiastic.
The Future of Empuraan
With the extended Eid weekend ahead and positive word-of-mouth, L2: Empuraan is poised to continue its phenomenal run. The film has the potential to become the highest-grossing Malayalam film ever. Will it achieve this ambitious feat? Only time will tell, but the early signs are overwhelmingly positive.
